Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Sara Pellegrino – Vice President, Investor and Public Relations Fred Vogt – Interim President and Chief Executive Officer Igor Bilinsky – Chief Operating Officer Jim Ziegler – Senior Vice President, Commercial Friedrich Finckenstein – Chief Medical Officer Jean-Marc Bellemin – Chief Financial Officer Conference Call Participants Tyler Van Buren – Cowen Michael Yee – Jefferies Peter ...